NCT07129655View on ClinicalTrials.gov

Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Cholangitis Post Kasai in Biliary Atresia)

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Biliary Atresia, Kasai Portoenterostomy StatusCholangitis
Trial Locations (1)

1205

Hôpitaux Universitaires de Genève, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT07129655 - Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Cholangitis Post Kasai in Biliary Atresia) | Biotech Hunter | Biotech Hunter